Log In
Print
BCIQ
Print
Print this Print this
 

Fluzone QIV (Fluzone Quadrivalent)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionInactivated quadrivalent influenza vaccine containing 2 strains of type A (H1N1 and H3N2) and 2 strains of type B (1 each from Yamagata and Victoria lineages) influenza
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsVaccinate against seasonal influenza virus in children ages 6 months to 8 years; Vaccinate against seasonal influenza virus in adults ages 18 and up; Vaccinate against seasonal influenza virus in adults ages 65 and up
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today